Advocacy
Practice development
News
CMS collecting comments on RAPID pathway for device coverage
The Centers for Medicare and Medicaid Services (CMS) is accepting comments on its proposal to speed up manufacturers’ ability to get new devices covered by Medicare. The Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway, first announced by CMS and the Food and Drug Administration (FDA) in April, will accelerate beneficiary access to eligible Class II FDA-designated Breakthrough Devices participating in FDA’s Total Product Life Cycle Advisory Program (TAP) and to eligible Class III FDA-designated Breakthrough Devices (regardless of TAP participation).
The RAPID coverage pathway is designed to reduce the review time between when the FDA authorizes a device for the market and when Medicare issues a national coverage determination (NCD). For devices in the RAPID coverage pathway, a proposed NCD will be issued the same day as FDA market authorization, meaning that national Medicare coverage could begin as soon as 60 days after FDA market authorization.
The public can comment on the procedural notice until Oct. 13.
More news from SIR
-
Guidewire
![]()
Senate attempts to pause OMB grant-making rule
![]()
The Senate-passed CR would fund the government through Dec. 11 and temporarily block OMB’s proposed federal financial assistance rule. SIR joined other healthcare organizations in opposing the proposal.
-
Guidewire
![]()
CMS collecting comments on RAPID pathway for device coverage
![]()
CMS is seeking feedback on its proposed RAPID pathway, which could reduce the time from FDA authorization to Medicare coverage for eligible breakthrough devices.
Advocacy
Coding, billing and reimbursement
-
Guidewire
![]()
Apply today for SIR Foundation awards!
![]()
If you plan on submitting an abstract to the SIR 2027 Annual Scientific Meeting, then you are eligible to apply for an SIR Foundation award! Learn more about each award and submit your application by Nov. 15.
Foundation
Research Funding: Awards
Featured
-
Guidewire
![]()
A new vision for JVIR
![]()
Our new editorial leadership brings fresh perspectives and expertise as we continue to advance the journal and serve the interventional radiology community.
JVIR
-
Guidewire
![]()
Quality reporting changes you need to know
![]()
CMS has proposed several changes to the Quality Payment Program (QPP) for the 2027 performance year that may affect quality reporting for interventional radiologists.
Quality improvement
-
Guidewire
![]()
Delve into endovascular therapy with SIR Foundation's Research Consensus Panel (RCP)
![]()
Srini Tummala, MD, FSIR, FSVM, and Ansar Z. Vance, MD, MSEd, will lead the upcoming RCP: The Increasing Role of Endovascular Therapy for Treatment of Common Femoral Artery Lesions.
Foundation
Research consensus panel
![]()
More news from SIR
![]()
-
Guidewire
Senate attempts to pause OMB grant-making rule
The Senate-passed CR would fund the government through Dec. 11 and temporarily block OMB’s proposed federal financial assistance rule. SIR joined other healthcare organizations in opposing the proposal.
-
Guidewire
CMS collecting comments on RAPID pathway for device coverage
CMS is seeking feedback on its proposed RAPID pathway, which could reduce the time from FDA authorization to Medicare coverage for eligible breakthrough devices.
Advocacy Coding, billing and reimbursement -
Guidewire
Apply today for SIR Foundation awards!
If you plan on submitting an abstract to the SIR 2027 Annual Scientific Meeting, then you are eligible to apply for an SIR Foundation award! Learn more about each award and submit your application by Nov. 15.
Foundation Research Funding: Awards Featured -
Guidewire
A new vision for JVIR
Our new editorial leadership brings fresh perspectives and expertise as we continue to advance the journal and serve the interventional radiology community.
JVIR -
Guidewire
Quality reporting changes you need to know
CMS has proposed several changes to the Quality Payment Program (QPP) for the 2027 performance year that may affect quality reporting for interventional radiologists.
Quality improvement -
Guidewire
Delve into endovascular therapy with SIR Foundation's Research Consensus Panel (RCP)
Srini Tummala, MD, FSIR, FSVM, and Ansar Z. Vance, MD, MSEd, will lead the upcoming RCP: The Increasing Role of Endovascular Therapy for Treatment of Common Femoral Artery Lesions.
Foundation Research consensus panel
More news from SIR